|
|
Blood, 15 May 2004, Vol. 103, No. 10, pp. 3897-3904.
Prepublished online as a Blood First Edition Paper on January 29, 2004; DOI 10.1182/blood-2003-11-4026.

Submitted November 25, 2003
Accepted January 18, 2004
Deregulated Expression in Ph+ Human Leukemias of AHI-1, a Gene Activated by Insertional Mutagenesis in Mouse Models of Leukemia
Xiaoyan Jiang*, Yun Zhao, Wing Yiu Chan, Suzanne Vercauteren, Emily Pang, Sean Kennedy, Frank Nicolini, Allen Eaves, and Connie Eaves
Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, BC, Canada; Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada
Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, BC, Canada
Hematology Department, Hospital E. Herriot, Lyon, France
Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, BC, Canada; Departments of Medicine, Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada
Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, BC, Canada; Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada; Departments of Medicine, Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada
* Corresponding author; email: xjiang{at}bccancer.bc.ca.
Ahi-1/AHI-1 encodes a family of protein isoforms containing one SH3 domain and multiple WD40-repeat domains. The function of these proteins is unknown but involvement in leukemogenesis has been suggested by the high frequency of Ahi-1 mutations seen in certain virus-induced murine leukemias. Here we show that in both mice and humans, Ahi-1/AHI-1 expression is highest in the most primitive hematopoietic cells with specific patterns of down-regulation in different lineages. Cells from patients with chronic myeloid leukemia (n=28) show elevated AHI-1 transcripts in all disease phases and, in chronic phase, in the leukemic cells at all stages of differentiation, including quiescent (G0) CD34+ cells as well as terminally differentiating cells. In the most primitive lin--CD34+CD38- CML cells, transcripts for the 2 shorter isoforms of AHI-1 are also increased. Although 15 of 16 human lymphoid and myeloid leukemic cell lines showed aberrant control of AHI-1 expression, this was not seen in blasts obtained directly from patients with acute Ph- leukemia (n=15). Taken together, our results suggest that down-regulation of AHI-1 expression is an important conserved step in primitive normal hematopoietic cell differentiation and that perturbations in AHI-1 expression may contribute to the development of specific types of human leukemia.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
Related Article in Blood Online:
-
TEL-AML1 and BCR-ABL: different leukemias, similar questions
- Linda Stork
Blood 2004 103: 3611-3612.
[Full Text]
[PDF]
This article has been cited by other articles:

|
 |

|
 |
 
B. K. Han, J. G. Jung, J. Nam, J. K. Moon, J. N. Kim, S. I. Lee, J. K. Kim, H. Kim, and J. Y. Han
Identification of the Major Proteins Produced by Cultured Germline Stem Cells in Chicken
J Androl,
November 1, 2009;
30(6):
690 - 702.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Kennah, A. Ringrose, L. L. Zhou, S. Esmailzadeh, H. Qian, M.-w. Su, Y. Zhou, and X. Jiang
Identification of tyrosine kinase, HCK, and tumor suppressor, BIN1, as potential mediators of AHI-1 oncogene in primary and transformed CTCL cells
Blood,
May 7, 2009;
113(19):
4646 - 4655.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. L. Zhou, Y. Zhao, A. Ringrose, D. DeGeer, E. Kennah, A. E.-J. Lin, G. Sheng, X.-J. Li, A. Turhan, and X. Jiang
AHI-1 interacts with BCR-ABL and modulates BCR-ABL transforming activity and imatinib response of CML stem/progenitor cells
J. Exp. Med.,
October 27, 2008;
205(11):
2657 - 2671.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Clappier, W. Cuccuini, A. Kalota, A. Crinquette, J.-M. Cayuela, W. A. Dik, A. W. Langerak, B. Montpellier, B. Nadel, P. Walrafen, et al.
The C-MYB locus is involved in chromosomal translocation and genomic duplications in human T-cell acute leukemia (T-ALL), the translocation defining a new T-ALL subtype in very young children
Blood,
August 15, 2007;
110(4):
1251 - 1261.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Jin, Y. Yamazaki, M. Takuwa, T. Takahara, K. Kaneko, T. Kuwata, S. Miyata, and T. Nakamura
Trib1 and Evi1 cooperate with Hoxa and Meis1 in myeloid leukemogenesis
Blood,
May 1, 2007;
109(9):
3998 - 4005.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. G. Jorgensen, M. Copland, E. K. Allan, X. Jiang, A. Eaves, C. Eaves, and T. L. Holyoake
Intermittent Exposure of Primitive Quiescent Chronic Myeloid Leukemia Cells to Granulocyte-Colony Stimulating Factor In vitro Promotes their Elimination by Imatinib Mesylate
Clin. Cancer Res.,
January 15, 2006;
12(2):
626 - 633.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|